Who owns VanEck Biotech ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BBH from SEC Form 13F filings across 114 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 114 institutions disclosed 702,099 shares of VanEck Biotech ETF worth $130.0M — about 36.5% of shares outstanding; the largest disclosed holder is GOLDMAN SACHS GROUP INC. Source: SEC Form 13F filings, parsed by EvidInvest.
114
13F holders
$130.0M
value, 2026 filers
36.5%
of shares outstanding (702,099 sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BBH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GOLDMAN SACHS GROUP INC | 102,020 | $20.7M | 0.0% | 5.3% | -0.1% |
| 2 | RAYMOND JAMES FINANCIAL INC | 65,619 | $13.3M | 0.0% | 3.4% | -5.7% |
| 3 | BANK OF AMERICA CORP /DE/ | 60,196 | $12.2M | 0.0% | 3.1% | -9.3% |
| 4 | GFS Advisors, LLC | 46,965 | $7,113 | 0.0% | 2.4% | +117.0% |
| 5 | MORGAN STANLEY | 39,574 | $8.0M | 0.0% | 2.1% | +20.2% |
| 6 | Miller Investment Management, LP | 38,226 | $7.8M | 0.7% | 2% | -1.9% |
| 7 | WELLS FARGO & COMPANY/MN | 33,244 | $6.8M | 0.0% | 1.7% | +1.3% |
| 8 | LPL Financial LLC | 30,131 | $6.1M | 0.0% | 1.6% | +13.5% |
| 9 | Conservest Capital Advisors, Inc. | 19,765 | $4.0M | 0.3% | 1% | -2.5% |
| 10 | Bleakley Financial Group, LLC | 16,260 | $3.3M | 0.0% | 0.8% | +5.4% |
| 11 | UBS Group AG | 15,809 | $3.2M | 0.0% | 0.8% | -4.7% |
| 12 | Paragon Private Wealth Management, LLC | 13,916 | $2.8M | 0.7% | 0.7% | -9.4% |
| 13 | ROYAL BANK OF CANADA | 13,403 | $2.7M | 0.0% | 0.7% | -3.2% |
| 14 | Integrated Wealth Concepts LLC | 12,278 | $2.5M | 0.0% | 0.6% | +1034.8% |
| 15 | Rockefeller Capital Management L.P. | 11,862 | $2.4M | 0.0% | 0.6% | 0.0% |
| 16 | COMMONWEALTH EQUITY SERVICES, LLC | 11,022 | $2.2M | 0.0% | 0.6% | +9.8% |
| 17 | ALTFEST L J & CO INC | 8,706 | $1.8M | 0.2% | 0.5% | +2.3% |
| 18 | Institute for Wealth Management, LLC. | 7,439 | $1.5M | 0.1% | 0.4% | 0.0% |
| 19 | STIFEL FINANCIAL CORP | 7,435 | $1.5M | 0.0% | 0.4% | +1.8% |
| 20 | PEAPACK GLADSTONE FINANCIAL CORP | 6,588 | $1,339 | 0.0% | 0.3% | -8.5% |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 6,545 | $1.3M | 0.0% | 0.3% | +153.8% |
| 22 | Wealthfront Advisers LLC | 5,984 | $1.2M | 0.0% | 0.3% | -14.6% |
| 23 | TWO SIGMA INVESTMENTS, LP | 5,600 | $1.1M | 0.0% | 0.3% | -8.2% |
| 24 | Cerity Partners LLC | 5,543 | $1.1M | 0.0% | 0.3% | -0.2% |
| 25 | CITADEL ADVISORS LLC | 5,463 | $1.1M | 0.0% | 0.3% | -42.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.